Current Status and Future Directions of Botulinum Neurotoxins for Targeting Pain Processing

Current evidence suggests that botulinum neurotoxins (BoNTs) A1 and B1, given locally into peripheral tissues such as skin, muscles, and joints, alter nociceptive processing otherwise initiated by inflammation or nerve injury in animal models and humans. Recent data indicate that such locally delive...

Descripción completa

Detalles Bibliográficos
Autores principales: Pellett, Sabine, Yaksh, Tony L., Ramachandran, Roshni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663519/
https://www.ncbi.nlm.nih.gov/pubmed/26556371
http://dx.doi.org/10.3390/toxins7114519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663519/
https://www.ncbi.nlm.nih.gov/pubmed/26556371
http://dx.doi.org/10.3390/toxins7114519

Ejemplares similares